diaziquone has been researched along with Neutropenia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bedikian, AY; Bodey, GP; Karlin, DA; Korinek, J; Stroehlein, JR | 1 |
| Baker, LH; Fletcher, WS; McCracken, JD; O'Bryan, RM; Shildt, R; Stephens, RL; Subramanian, VP | 1 |
2 other study(ies) available for diaziquone and Neutropenia
| Article | Year |
|---|---|
Phase II clinical evaluation of AZQ in colorectal cancer.
Topics: Adult; Aged; Antineoplastic Agents; Aziridines; Azirines; Benzoquinones; Colonic Neoplasms; Drug Administration Schedule; Drug Evaluation; Female; Humans; Male; Middle Aged; Neutropenia; Rectal Neoplasms; Thrombocytopenia | 1982 |
Phase II trial of diaziquone in advanced large bowel carcinoma in previously treated and untreated patients: a Southwest Oncology Group Study.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Aziridines; Azirines; Benzoquinones; Colonic Neoplasms; Drug Evaluation; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Neutropenia; Thrombocytopenia | 1985 |